GSK vaccine expansion, Apple bends to Beijing pressure

🌅 Today's Morning Call

S&P Futures 6,703.50 ▲ +26.00 (+0.39%)	Nasdaq Futures 24,655.75 ▲ +95.75 (+0.39%)	Dow Futures 46,914.00 ▲ +193.00 (+0.41%)
10Y Treasury 4.27% ▲ +0.06%	US Dollar 100.06 ▲ +0.30 (+0.30%)	Bitcoin $72,400 ▲ +$1,907 (+2.70%)

Good morning! It's Friday the 13th and the markets are defying superstition. Futures are pointing to a solid open across all three major indexes, with tech leading the charge higher and the dollar flexing its muscles. From vaccine approvals to geopolitical energy deals, there's plenty moving before the opening bell.

👀 What to Watch Today

GSK is stealing the spotlight this morning after the FDA expanded approval for its Arexvy RSV vaccine to adults aged 18 to 49 who face elevated risk. The British pharma giant just unlocked a massive new addressable market beyond the older demographic that was previously approved. This is a significant competitive edge in the respiratory vaccine space, especially as RSV awareness grows beyond pediatric and elderly populations.

Apple (AAPL) is making waves with its decision to slash App Store commission fees in mainland China following what developers describe as government pressure. The move marks a rare capitulation from Cupertino and signals just how important the Chinese market remains to Apple's long-term strategy. Expect analysts to parse what this means for margins and whether similar pressure campaigns could spread to other markets.

On the energy front, the Kremlin characterized a U.S. sanctions waiver on Russian oil as a mutual effort to stabilize global energy markets. Kremlin spokesman Dmitry Peskov framed it as common interest between Washington and Moscow, a notable development given ongoing geopolitical tensions. Oil traders will be watching how this impacts crude pricing and whether it signals a broader thaw or just tactical maneuvering ahead of summer driving season.

Collect Your $21K — Courtesy of Donald Trump 🇺🇸 [ad]

🌏 Overnight Recap

Asian markets closed mixed overnight as traders digested regional economic data and positioned ahead of the U.S. session. Tokyo showed resilience while Hong Kong tech stocks faced pressure on regulatory concerns that extend beyond Apple's fee adjustments. The Hang Seng struggled to find footing as investors weighed whether Beijing's pressure campaign on foreign tech firms will intensify or plateau.

European bourses are trading cautiously higher this morning, with energy and healthcare stocks providing support. The STOXX 600 is up modestly as GSK shares jump on the Arexvy news, giving the London market a boost. Meanwhile, crude oil is holding steady as traders process the implications of relaxed Russian sanctions and what it means for OPEC+ production strategy going forward.

Treasury yields are ticking higher across the curve, with the 10-year climbing 6 basis points to 4.27 percent. The move suggests bond traders are pricing in either stronger economic data or reassessing the Fed's rate path. Bitcoin is enjoying a nice 2.7 percent pop to $72,400, riding the risk-on wave that's lifting equity futures.

Is this Elon's WORST nightmare? [ad]

📊 Pre-Market Movers

GSK is the clear pre-market winner after securing expanded FDA approval for Arexvy, its RSV vaccine now cleared for at-risk adults as young as 18. The approval dramatically expands the target population and positions GSK ahead of competitors in a vaccine category that's finally getting the attention it deserves. Expect heavy volume when London markets hand off to New York.

Apple (AAPL) is seeing modest pre-market activity as investors digest the China fee cut announcement. While the headline reads as a concession, some analysts are framing it as smart diplomacy that protects Apple's critical manufacturing and consumer base in the region. The question is whether this sets a precedent that other governments will exploit or if it's a one-off carve-out for Beijing.

Broader tech names are catching a bid in sympathy with strong Nasdaq futures, while energy stocks are getting a fresh look following the Russia sanctions development. The XLE energy ETF components could see increased interest as traders game out what stabilized oil markets mean for producer profitability versus consumer relief at the pump.

Trump’s 2020 CIA Director Pick Joins Paradigm [ad]

🔍 Today's Watchlist

1. GSK expansion into younger RSV demographics and competitive response
2. Apple margin impact from China App Store fee reduction
3. Energy sector reaction to Russia sanctions waiver news
4. Treasury yield movement and Fed rate path implications
5. Tech sector momentum as Nasdaq futures lead the advance

🎯 The Morning Playbook

The setup for Friday is straightforward: ride the momentum but keep your radar tuned for any surprises. With futures green across the board and several catalysts in play, there's opportunity in healthcare, tech, and energy names. GSK's vaccine win shows that regulatory approvals still matter and can move stocks meaningfully, while Apple's China move is a reminder that geopolitical navigation is now a core competency for mega-cap tech.

Keep an eye on how energy stocks react to the Russia sanctions news throughout the session. If crude stays stable and the narrative shifts toward supply certainty, refiners and integrated majors could outperform. On the flip side, watch whether rising yields put any pressure on high-multiple growth stocks as the morning progresses.

It's Friday the 13th, but the market's handing you a gift basket of green futures and genuine catalysts. Sometimes the best play is simply showing up and letting the news do the heavy lifting. Trade what you see, not what you fear, and remember that superstitions don't pay the bills. Smart positioning does.

ALERT: Drop these 5 stocks! [ad]